Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lasofoxifene (CP-336,156), a novel selective estrogen receptor modulator, in preclinical studies.

Journal of the American Aging Association·2013
Same author

Aging and sarcopenia.

Journal of musculoskeletal & neuronal interactions·2007
Same author

Effects of gestational age on prostaglandin EP receptor expression and functional involvement during in vitro contraction of the guinea pig uterus.

Prostaglandins, leukotrienes, and essential fatty acids·2007
Same author

Role of EP2 and EP4 receptor-selective agonists of prostaglandin E(2) in acute and chronic kidney failure.

Kidney international·2006
Same author

Selective androgen receptor modulators--prospects for emerging therapy in osteoporosis?

Journal of musculoskeletal & neuronal interactions·2005
Same author

Osteopenia and impaired fracture healing in aged EP4 receptor knockout mice.

Bone·2005

Related Experiment Video

Updated: Jul 14, 2026

Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry
11:20

Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry

Published on: March 29, 2018

Prostaglandin E(2) receptors in bone formation.

M Li1, D D Thompson, V M Paralkar

  • 1Pfizer Global Research and Development, Groton Laboratories, Mail Stop 8118W-208, Groton, CT, 06340, USA, mei.li@pfizer.com

International Orthopaedics
|June 27, 2007
PubMed
Summary

Prostaglandin E2 (PGE2) has therapeutic potential for bone healing. Selective agonists targeting EP2 and EP4 receptors show promise for enhancing bone formation and repair in preclinical models.

More Related Videos

Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery
12:27

Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery

Published on: August 22, 2016

Osteoclast Derivation from Mouse Bone Marrow
06:17

Osteoclast Derivation from Mouse Bone Marrow

Published on: November 6, 2014

Related Experiment Videos

Last Updated: Jul 14, 2026

Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry
11:20

Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry

Published on: March 29, 2018

Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery
12:27

Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery

Published on: August 22, 2016

Osteoclast Derivation from Mouse Bone Marrow
06:17

Osteoclast Derivation from Mouse Bone Marrow

Published on: November 6, 2014

Area of Science:

  • Biomedical Science
  • Pharmacology
  • Orthopedics

Background:

  • Prostaglandins, particularly Prostaglandin E2 (PGE2), exhibit diverse physiological effects.
  • Systemic administration of PGE2 is limited by side effects, despite its roles in bone healing and formation.
  • PGE2 mediates its actions via four G protein-coupled receptor subtypes: EP1, EP2, EP3, and EP4.

Purpose of the Study:

  • To review the role of EP receptors in bone formation and healing.
  • To focus on studies involving EP receptor knockout (KO) mice and EP2/EP4 selective agonist treatments.

Main Methods:

  • Analysis of existing literature on EP receptor function in bone.
  • Review of studies utilizing EP receptor knockout mouse models.
  • Examination of data from animal models treated with EP2 or EP4 selective agonists.

Main Results:

  • EP2 and EP4 receptors are crucial regulators of bone formation and resorption.
  • Selective EP2 and EP4 receptor agonists stimulate bone formation and increase bone mass in animal models.
  • Agonist administration accelerates fracture healing and bone defect repair in preclinical studies.

Conclusions:

  • Targeting EP2 and EP4 receptors offers a promising therapeutic strategy for bone regeneration.
  • Selective agonists may provide novel treatments for enhancing bone formation and repair in humans.
  • Further research into EP receptor pathways could unlock new bone anabolic therapies.